Mark Crockett, MDMolecular ImagingTargeted radiopharmaceuticals offer new hope for longer 'healthspans'Precision radiopharmaceuticals accurately target tumors while minimizing damage to healthy tissue, presenting an opportunity to extend not just lifespans but “healthspans,” Mark Crockett, MD, explains in this article.March 15, 2024Page 1 of 1Top StoriesMRIMRI shows promise profiling hepatocellular carcinoma tumorsA study suggests that imaging-based screening with targeted pathological workup could help refine treatment strategies.Womens ImagingMRI-based DL model improves ovarian lesion classificationAIOpen-source DL model does well for identifying lung cancer riskWomens ImagingFewer Black women may be eligible for supplemental imaging for dense breastsMolecular ImagingPET/CT reliable for diagnosing fracture-related infections
